Cambridge NeuroWorks
Cambridge NeuroWorks will support the development of breakthrough technologies, from electronic brain implants to brain-computer interfaces, designed to improve lives globally.
Cambridge joins forces with Advanced Research and Invention Agency (ARIA) to rocket-boost progress on a new generation of neuro-technologies designed to treat conditions such as depression, dementia, chronic pain, epilepsy and injuries to the nervous system.
Neurological and mental health disorders will affect four in every five people in their lifetimes and present a greater overall health burden than cancer and cardiovascular disease combined. Neuro-technology – where technology is used to control the nervous system - has the potential to deliver revolutionary new treatments for these disorders.
The science of building technology small enough, precise enough and cheap enough to make a global impact requires an environment where the very best minds from across the UK can collaborate, dream up radical, risky ideas and test them without fear of failure.
Introducing Cambridge NeuroWorks
This innovative programme will support the development of breakthrough technologies, from electronic brain implants to brain-computer interfaces, designed to improve lives globally. With a focus on reducing risks and side effects of implants and enabling accessible treatments for millions, Cambridge NeuroWorks is a game-changer in the neuro-health field.
